QIAGEN N.V. (QGEN) › Cost of RevenueQIAGEN N.V. (QGEN) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $493.34M2017: $494.98M2018: $500.89M2019: $521.16M2020: $637.63M2021: $800.84M2022: $756.96M2023: $731.62M2024: $1.01B2025: $790.50M$790.50M2016Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$790.50M-21.8%2024$1.01B+38.2%2023$731.62M-3.3%2022$756.96M-5.5%2021$800.84M+25.6%2020$637.63M+22.3%2019$521.16M+4.0%2018$500.89M+1.2%2017$494.98M+0.3%2016$493.34M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share